Lexaria Bioscience Corp (LEXX) — Net Asset Quality Index
Lexaria Bioscience Corp (LEXX) has a Net Asset Quality Index of 95.7% as of February 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $6.49 Million minus total liabilities of $277.00K yields net assets of $6.21 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Lexaria Bioscience Corp to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Lexaria Bioscience Corp Net Asset Quality Index Over Time (2005–2025)
This chart shows how Lexaria Bioscience Corp's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of February 2026, the index stands at 95.7%, representing net assets of $6.21 Million against total assets of $6.49 Million USD. See Lexaria Bioscience Corp working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Lexaria Bioscience Corp (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Lexaria Bioscience Corp from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Lexaria Bioscience Corp (LEXX) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.3% | $2.60 Million | $4.18 Million | $1.57 Million | ▼ -24.0 pp |
| 2024 | 86.4% | $7.66 Million | $8.87 Million | $1.21 Million | ▼ -0.5 pp |
| 2023 | 86.9% | $2.68 Million | $3.08 Million | $403.91K | ▼ -10.5 pp |
| 2022 | 97.4% | $7.63 Million | $7.83 Million | $201.44K | ▼ -1.0 pp |
| 2021 | 98.5% | $13.06 Million | $13.27 Million | $203.26K | ▲ +10.7 pp |
| 2020 | 87.8% | $2.48 Million | $2.83 Million | $345.98K | ▼ -5.3 pp |
| 2019 | 93.1% | $2.49 Million | $2.68 Million | $184.51K | ▼ -5.1 pp |
| 2018 | 98.2% | $2.39 Million | $2.43 Million | $43.64K | ▲ +1.4 pp |
| 2017 | 96.8% | $2.77 Million | $2.86 Million | $92.35K | ▲ +81.3 pp |
| 2016 | 15.5% | $87.76K | $566.64K | $478.88K | ▼ -76.8 pp |
| 2015 | 92.3% | $656.60K | $711.72K | $55.12K | ▲ +33.5 pp |
| 2014 | 58.7% | $2.10 Million | $3.57 Million | $1.47 Million | ▲ +0.0 pp |
| 2013 | 58.7% | $2.10 Million | $3.57 Million | $1.47 Million | ▼ -1.7 pp |
| 2012 | 60.4% | $2.23 Million | $3.68 Million | $1.46 Million | ▼ -0.9 pp |
| 2011 | 61.3% | $2.66 Million | $4.34 Million | $1.68 Million | ▼ -0.5 pp |
| 2010 | 61.8% | $2.39 Million | $3.86 Million | $1.48 Million | ▼ -2.7 pp |
| 2009 | 64.5% | $2.21 Million | $3.42 Million | $1.21 Million | ▼ -11.2 pp |
| 2008 | 75.7% | $2.46 Million | $3.25 Million | $788.18K | ▼ -13.7 pp |
| 2007 | 89.4% | $3.39 Million | $3.80 Million | $400.98K | ▲ +63.5 pp |
| 2006 | 25.9% | $704.55K | $2.72 Million | $2.01 Million | ▼ -73.1 pp |
| 2005 | 99.0% | $1.09 Million | $1.10 Million | $11.18K | — |